Xiaowen Feng

Xiaowen Feng is an experienced professional in the venture capital and biotechnology sectors, currently serving as Managing Partner at Forcefield Ventures and Venture Partner at IMO Ventures since 2018. Xiaowen also holds director positions on the boards of META Pharmaceuticals Inc., Regenerative Bio Inc., and PixelBiotech GmbH, while functioning as Chief Strategy Officer at Regenerative Bio Inc. Additionally, Xiaowen co-founded Kula Bio in 2018. Prior to these roles, Xiaowen completed a postdoctoral research position at Harvard University from 2015 to 2019 and earned a PhD in Chemistry from the University of California, Berkeley, as well as a BS in Chemistry from Peking University.